proteinchip™ analysis Search Results


proteinchip seldi-tof-ms analysis  (Ciphergen inc)
90
Ciphergen inc proteinchip seldi-tof-ms analysis
Differentially expressed ovarian cancer-associated serum proteins. (A) Detection of differentially expressed ovarian cancer-associated serum proteins. A representative pseudogel view of <t>SELDI-TOF-MS</t> analysis of serum samples, processed on a SAX2 chip surface, shows relative abundance of potential ovarian cancer markers. The six spectral protein profiles at the top represent serum from healthy individuals, three benign samples are represented in the middle section, and the six spectral profiles on the bottom represent serum from patients with ovarian cancer. (B) Representative spectral overlay of serum from a healthy (solid line) vs. diseased (dashed line) individual. The overlay shows that there is a decrease of protein 13.9kDa in serum from ovarian cancer patients, whereas concurrently there is an increase of the proteins 15.1kDa and 15.9kDa. Numbers in the mass spectra represent the observed mass of the marker in that particular sample.
Proteinchip Seldi Tof Ms Analysis, supplied by Ciphergen inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/proteinchip seldi-tof-ms analysis/product/Ciphergen inc
Average 90 stars, based on 1 article reviews
proteinchip seldi-tof-ms analysis - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
proteinchip™ analysis  (Ciphergen inc)
90
Ciphergen inc proteinchip™ analysis
Differentially expressed ovarian cancer-associated serum proteins. (A) Detection of differentially expressed ovarian cancer-associated serum proteins. A representative pseudogel view of <t>SELDI-TOF-MS</t> analysis of serum samples, processed on a SAX2 chip surface, shows relative abundance of potential ovarian cancer markers. The six spectral protein profiles at the top represent serum from healthy individuals, three benign samples are represented in the middle section, and the six spectral profiles on the bottom represent serum from patients with ovarian cancer. (B) Representative spectral overlay of serum from a healthy (solid line) vs. diseased (dashed line) individual. The overlay shows that there is a decrease of protein 13.9kDa in serum from ovarian cancer patients, whereas concurrently there is an increase of the proteins 15.1kDa and 15.9kDa. Numbers in the mass spectra represent the observed mass of the marker in that particular sample.
Proteinchip™ Analysis, supplied by Ciphergen inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/proteinchip™ analysis/product/Ciphergen inc
Average 90 stars, based on 1 article reviews
proteinchip™ analysis - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
proteinchip analysis  (Verlag GmbH)
90
Verlag GmbH proteinchip analysis
Differentially expressed ovarian cancer-associated serum proteins. (A) Detection of differentially expressed ovarian cancer-associated serum proteins. A representative pseudogel view of <t>SELDI-TOF-MS</t> analysis of serum samples, processed on a SAX2 chip surface, shows relative abundance of potential ovarian cancer markers. The six spectral protein profiles at the top represent serum from healthy individuals, three benign samples are represented in the middle section, and the six spectral profiles on the bottom represent serum from patients with ovarian cancer. (B) Representative spectral overlay of serum from a healthy (solid line) vs. diseased (dashed line) individual. The overlay shows that there is a decrease of protein 13.9kDa in serum from ovarian cancer patients, whereas concurrently there is an increase of the proteins 15.1kDa and 15.9kDa. Numbers in the mass spectra represent the observed mass of the marker in that particular sample.
Proteinchip Analysis, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/proteinchip analysis/product/Verlag GmbH
Average 90 stars, based on 1 article reviews
proteinchip analysis - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Differentially expressed ovarian cancer-associated serum proteins. (A) Detection of differentially expressed ovarian cancer-associated serum proteins. A representative pseudogel view of SELDI-TOF-MS analysis of serum samples, processed on a SAX2 chip surface, shows relative abundance of potential ovarian cancer markers. The six spectral protein profiles at the top represent serum from healthy individuals, three benign samples are represented in the middle section, and the six spectral profiles on the bottom represent serum from patients with ovarian cancer. (B) Representative spectral overlay of serum from a healthy (solid line) vs. diseased (dashed line) individual. The overlay shows that there is a decrease of protein 13.9kDa in serum from ovarian cancer patients, whereas concurrently there is an increase of the proteins 15.1kDa and 15.9kDa. Numbers in the mass spectra represent the observed mass of the marker in that particular sample.

Journal:

Article Title: Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: Potential use in diagnosis and prognosis

doi: 10.1073/pnas.2033602100

Figure Lengend Snippet: Differentially expressed ovarian cancer-associated serum proteins. (A) Detection of differentially expressed ovarian cancer-associated serum proteins. A representative pseudogel view of SELDI-TOF-MS analysis of serum samples, processed on a SAX2 chip surface, shows relative abundance of potential ovarian cancer markers. The six spectral protein profiles at the top represent serum from healthy individuals, three benign samples are represented in the middle section, and the six spectral profiles on the bottom represent serum from patients with ovarian cancer. (B) Representative spectral overlay of serum from a healthy (solid line) vs. diseased (dashed line) individual. The overlay shows that there is a decrease of protein 13.9kDa in serum from ovarian cancer patients, whereas concurrently there is an increase of the proteins 15.1kDa and 15.9kDa. Numbers in the mass spectra represent the observed mass of the marker in that particular sample.

Article Snippet: Ciphergen ProteinChip SELDI-TOF-MS Analysis.

Techniques: Marker